Taysha Gene Therapies Inc (TSHA)

Cost of Revenue

$0.00

Quarterly · Period ending: · USD

TSHA logo

TSHA Cost of Revenue

Latest reported$0.00
TSHA Quarterly Cost of Revenue ($0.00 → $0.00)
High-resolution chart · PNG

TSHA cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Taysha Gene Therapies Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
0
295,000
299,000
286,000
0
0
0
0
0
0
0
331,000
703,000
631,000
1,679,000
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.